Mutual Fund Ownership
Ownership as on: Mon, 25 Nov, 2024

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)16.97
% of AUM4.18%

Kotak Consumption Fund Regular Growth

NA
Equity
Amount Invested (Cr.)32.70
% of AUM3.05%

Kotak Special Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)54.53
% of AUM2.40%

JM Small Cap Fund Regular Growth

NA
Equity
Amount Invested (Cr.)12.13
% of AUM2.09%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)27.39
% of AUM1.98%

FAQs about Jubilant Pharmova share price

Jubilant Pharmova is trading at 1112.45 as on Mon Nov 25 2024 09:54:16. This is -2.52% lower as compared to its previous closing price of 1141.20.

The market capitalization of Jubilant Pharmova is 18033.47 Cr as on Mon Nov 25 2024 09:54:16.

The average broker rating on Jubilant Pharmova is Strong Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Jubilant Pharmova is 1309.00 whereas the 52 wk low is 408.60

Jubilant Pharmova can be analyzed on the following key metrics -

  • TTM P/E: 30.76
  • Sector P/E: 33.29
  • Dividend Yield: 0.44%
  • D/E ratio: 0.52

Jubilant Pharmova reported a net profit of 77.10 Cr in 2024.

Recommended For You
Trending Stocks
3,756.05+151.50(4.20%)
1,781.55+35.60(2.04%)
2,458.50-20.50 (-0.83%)
1,733.70-14.00 (-0.80%)
HomeMarketsPremiumInstant LoanMint Shorts